TNF alpha as a therapeutic target in rheumatoid arthritis.

TNF alpha as a therapeutic target in rheumatoid arthritis.

Rheumatoid arthritis (RA) is an autoimmune disease with inflammatory manifestations in the peripheral synovial joints, which are infiltrated by activated T cells, macrophages, and plasma cells. We have investigated the role of cytokines in RA and have proposed that tumour necrosis factor has a pivot...

Descripció completa

Dades bibliogràfiques
Autors principals:	Feldmann, M, Brennan, F, Elliott, M, Katsikis, P, Maini, R
Format:	Journal article
Idioma:	English
Publicat:	1994

Ítems similars

TNF alpha is an effective therapeutic target for rheumatoid arthritis.
per: Feldmann, M, et al.
Publicat: (1995)

Targeting TNF alpha for the therapy of rheumatoid arthritis.
per: Maini, R, et al.
Publicat: (1994)

Discovery of TNF-alpha as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies.
per: Feldmann, M, et al.
Publicat: (2002)

From the laboratory to the clinic: Evaluation of cytokines in rheumatoid arthritis highlights TNF-alpha as a new therapeutic target
per: Feldmann, M, et al.
Publicat: (1994)

TNF alpha--a pivotal role in rheumatoid arthritis?
per: Brennan, F, et al.
Publicat: (1992)

TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
per: Maini, R, et al.
Publicat: (1993)

The cytokine network in rheumatoid arthritis: definition of TNF alpha as a therapeutic target.
per: Feldmann, M
Publicat: (1996)

The role of TNF alpha and IL-1 in rheumatoid arthritis.
per: Feldmann, M, et al.
Publicat: (2001)

Evaluation of the role of cytokines in autoimmune disease: the importance of TNF alpha in rheumatoid arthritis.
per: Feldmann, M, et al.
Publicat: (1992)

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
per: Maini, R, et al.
Publicat: (1995)

TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases
per: Feldmann, M, et al.
Publicat: (2003)

Discovery of TNF-α as a therapeutic target in rheumatoid arthritis: Preclinical and clinical studies
per: Feldmann, M, et al.
Publicat: (2002)

TNF alpha blockade in rheumatoid arthritis: rationale, clinical outcomes and mechanisms of action.
per: Elliott, M, et al.
Publicat: (1995)

TNF blockade in rheumatoid arthritis: implications for therapy and pathogenesis.
per: Maini, R, et al.
Publicat: (1997)

TNFα - A pivotal role in rheumatoid arthritis?
per: Brennan, F, et al.
Publicat: (1992)

ANTI TNF THERAPY IN RHEUMATOID ARTHRITIS
per: Feldmann, M, et al.
Publicat: (2011)

Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of action.
per: Feldmann, M, et al.
Publicat: (1995)

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
per: Feldmann, M, et al.
Publicat: (2001)

Selective immunosuppression of tumour necrosis factor-alpha in rheumatoid arthritis.
per: Brennan, F, et al.
Publicat: (1995)

Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases.
per: Feldmann, M, et al.
Publicat: (2003)

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis.
per: Brennan, F, et al.
Publicat: (1989)

TNF as a therapeutic target
per: Bondeson, J, et al.
Publicat: (2000)

Molecular therapeutic targets in rheumatoid arthritis.
per: Sacre, S, et al.
Publicat: (2005)

TNFα blockade in rheumatoid arthritis: Rationale, clinical outcomes and mechanisms of action
per: Elliott, M, et al.
Publicat: (1995)

Rheumatoid arthritis: Pathogenic mechanisms and therapeutic targets
per: Taylor, P, et al.
Publicat: (2004)

Immunoregulatory role of interleukin 10 in rheumatoid arthritis.
per: Katsikis, P, et al.
Publicat: (1994)

Anti-TNF alpha therapy in rheumatoid arthritis--current and future directions.
per: Taylor, P, et al.
Publicat: (2000)

Insights into the pathogenesis of rheumatoid arthritis from application of anti-TNF therapy.
per: Maini, R, et al.
Publicat: (2000)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
per: Elliott, M, et al.
Publicat: (1993)

TNF inhibitors are produced spontaneously by rheumatoid and osteoarthritic synovial joint cell cultures: evidence of feedback control of TNF action.
per: Brennan, F, et al.
Publicat: (1995)

Rheumatoid arthritis.
per: Feldmann, M, et al.
Publicat: (1996)

Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease.
per: Maini, R, et al.
Publicat: (1995)

Development of anti-TNF therapy for rheumatoid arthritis.
per: Feldmann, M
Publicat: (2002)

Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis.
per: Foey, A, et al.
Publicat: (2003)

Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis.
per: Feldmann, M, et al.
Publicat: (1997)

Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics.
per: Feldmann, M, et al.
Publicat: (2008)

Role of cytokines in rheumatoid arthritis.
per: Feldmann, M, et al.
Publicat: (1996)

Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.
per: Charles, P, et al.
Publicat: (1999)

Anti-TNF alpha therapy is useful in rheumatoid arthritis and Crohn's disease: analysis of the mechanism of action predicts utility in other diseases.
per: Feldman, M, et al.
Publicat: (1998)

The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis.
per: Feldmann, M, et al.
Publicat: (2004)